Over 65% of people with obesity display the metabolic-associated fatty liver disease
(MAFLD), which can manifest as steatohepatitis, fibrosis, cirrhosis, or liver cancer. The …

There is substantial debate about the intrinsic relationship between insulin resistance, the
metabolic syndrome (MetS) and nonalcoholic fatty liver disease (NAFLD). While NAFLD has …

Non-alcoholic fatty liver disease (NAFLD) is a definition of a prevalent condition that has
been given a name describing what the disease is not, mainly due to gaps in the …

The comprehensive anabolic effects of insulin throughout the body, in addition to the control
of glycemia, include ensuring lipid homeostasis and anti-inflammatory modulation …

Background The role of metabolic/inflammatory hormonal systems in metabolic dysfunction
associated steatotic liver disease (MASLD) remains to be fully elucidated. Purpose To report …

Insulin resistance is a common feature of obesity and type 2 diabetes, but novel approaches
of diabetes subtyping (clustering) revealed variable degrees of insulin resistance in people …

The number of people with diabetes worldwide is increasing annually, resulting in a serious
economic burden. Insulin resistance is a major pathology in the early onset of diabetes …

Research on lean, energy-deficient athletic and military cohorts has broadened the concept
of the Female Athlete Triad into the Relative Energy Deficiency in Sport (REDs) syndrome …

Diabetes mellitus is a heterogeneous disease characterized by hyperglycemia due to
impaired insulin secretion and/or action. All diabetes types have a strong genetic …

ABSTRACT Aim Subjects with Familial Partial Lipodystrophy type 2 (FPLD2) are at high risk
to develop diabetes. To better understand the natural history and variability of this disease …